 | • レポートコード：QYR9NV17815 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、クリプトコッカス薬の世界市場について調査・分析し、クリプトコッカス薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アムホテリシンB、フルシトシン、フルコナゾール、その他）、用途別（病院薬局、小売薬局、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のクリプトコッカス薬市場動向 ・主要企業別マーケットシェア ・クリプトコッカス薬の種類別市場規模2014-2019 （アムホテリシンB、フルシトシン、フルコナゾール、その他） ・クリプトコッカス薬の用途別市場規模2014-2019 （病院薬局、小売薬局、その他） ・クリプトコッカス薬の北米市場：主要企業・種類別/用途別市場規模 ・クリプトコッカス薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・クリプトコッカス薬の中国市場：主要企業・種類別/用途別市場規模 ・クリプトコッカス薬の日本国内市場：主要企業・種類別/用途別市場規模 ・クリプトコッカス薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・クリプトコッカス薬のインド市場：主要企業・種類別/用途別市場規模 ・クリプトコッカス薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott、Pfizer、Bristol-Mayers Squibb、Sigmapharm Laboratories、Novartis、Glenmark Pharmaceuticals） ・クリプトコッカス薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, called meningitis.Symptoms of the disease include – fever, headache, fatigue, dry cough and blurred vision.It can be treated by dozing off with amphotericin B, fluorocytosine and fluconazole.In 2018, the global Cryptococcosis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cryptococcosis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cryptococcosis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott
Pfizer
Bristol-Mayers Squibb
Sigmapharm Laboratories
Novartis
Glenmark Pharmaceuticals
…
Market segment by Type, the product can be split into
Amphotericin B
Flucytosine
Fluconazole
Others
Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacies
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cryptococcosis Drugs status, future forecast, growth opportunity, key market and key players.
To present the Cryptococcosis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cryptococcosis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cryptococcosis Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Amphotericin B
1.4.3 Flucytosine
1.4.4 Fluconazole
1.4.5 Others
1.5 Market by Application
1.5.1 Global Cryptococcosis Drugs Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacies
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cryptococcosis Drugs Market Size
2.2 Cryptococcosis Drugs Growth Trends by Regions
2.2.1 Cryptococcosis Drugs Market Size by Regions (2019-2025)
2.2.2 Cryptococcosis Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Cryptococcosis Drugs Market Size by by Players
3.1.1 Global Cryptococcosis Drugs Revenue by by Players (2014-2019)
3.1.2 Global Cryptococcosis Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Cryptococcosis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Cryptococcosis Drugs Key Players Head office and Area Served
3.3 Key Players Cryptococcosis Drugs Product/Solution/Service
3.4 Date of Enter into Cryptococcosis Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cryptococcosis Drugs Market Size by Type (2014-2019)
4.2 Global Cryptococcosis Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Cryptococcosis Drugs Market Size (2014-2019)
5.2 Cryptococcosis Drugs Key Players in North America
5.3 North America Cryptococcosis Drugs Market Size by Type
5.4 North America Cryptococcosis Drugs Market Size by Application
6 Europe
6.1 Europe Cryptococcosis Drugs Market Size (2014-2019)
6.2 Cryptococcosis Drugs Key Players in Europe
6.3 Europe Cryptococcosis Drugs Market Size by Type
6.4 Europe Cryptococcosis Drugs Market Size by Application
7 China
7.1 China Cryptococcosis Drugs Market Size (2014-2019)
7.2 Cryptococcosis Drugs Key Players in China
7.3 China Cryptococcosis Drugs Market Size by Type
7.4 China Cryptococcosis Drugs Market Size by Application
8 Japan
8.1 Japan Cryptococcosis Drugs Market Size (2014-2019)
8.2 Cryptococcosis Drugs Key Players in Japan
8.3 Japan Cryptococcosis Drugs Market Size by Type
8.4 Japan Cryptococcosis Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cryptococcosis Drugs Market Size (2014-2019)
9.2 Cryptococcosis Drugs Key Players in Southeast Asia
9.3 Southeast Asia Cryptococcosis Drugs Market Size by Type
9.4 Southeast Asia Cryptococcosis Drugs Market Size by Application
10 India
10.1 India Cryptococcosis Drugs Market Size (2014-2019)
10.2 Cryptococcosis Drugs Key Players in India
10.3 India Cryptococcosis Drugs Market Size by Type
10.4 India Cryptococcosis Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Cryptococcosis Drugs Market Size (2014-2019)
11.2 Cryptococcosis Drugs Key Players in Central & South America
11.3 Central & South America Cryptococcosis Drugs Market Size by Type
11.4 Central & South America Cryptococcosis Drugs Market Size by Application
12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cryptococcosis Drugs Introduction
12.1.4 Abbott Revenue in Cryptococcosis Drugs Business (2014-2019))
12.1.5 Abbott Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cryptococcosis Drugs Introduction
12.2.4 Pfizer Revenue in Cryptococcosis Drugs Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Bristol-Mayers Squibb
12.3.1 Bristol-Mayers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cryptococcosis Drugs Introduction
12.3.4 Bristol-Mayers Squibb Revenue in Cryptococcosis Drugs Business (2014-2019)
12.3.5 Bristol-Mayers Squibb Recent Development
12.4 Sigmapharm Laboratories
12.4.1 Sigmapharm Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cryptococcosis Drugs Introduction
12.4.4 Sigmapharm Laboratories Revenue in Cryptococcosis Drugs Business (2014-2019)
12.4.5 Sigmapharm Laboratories Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cryptococcosis Drugs Introduction
12.5.4 Novartis Revenue in Cryptococcosis Drugs Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Glenmark Pharmaceuticals
12.6.1 Glenmark Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cryptococcosis Drugs Introduction
12.6.4 Glenmark Pharmaceuticals Revenue in Cryptococcosis Drugs Business (2014-2019)
12.6.5 Glenmark Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cryptococcosis Drugs Key Market Segments
Table Key Players Cryptococcosis Drugs Covered
Table Global Cryptococcosis Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Amphotericin B Figures
Table Key Players of Amphotericin B
Figuer Flucytosine Figures
Table Key Players of Flucytosine
Figuer Fluconazole Figures
Table Key Players of Fluconazole
Figuer Others Figures
Table Key Players of Others
Table Global Cryptococcosis Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Cryptococcosis Drugs Market Share by Application in 2018 & 2025
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacies Case Studies
Figure Other Case Studies
Figure Cryptococcosis Drugs Report Years Considered
Figure Global Cryptococcosis Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cryptococcosis Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Cryptococcosis Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Cryptococcosis Drugs Market Share by Regions 2014-2019
Figure Global Cryptococcosis Drugs Market Share by Regions 2014-2019
Figure Global Cryptococcosis Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Cryptococcosis Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Cryptococcosis Drugs Market Share by by Players (2014-2019)
Figure Global Cryptococcosis Drugs Market Share by by Players in 2018
Table Global Cryptococcosis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cryptococcosis Drugs Product/Solution/Service
Table Date of Enter into Cryptococcosis Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cryptococcosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Cryptococcosis Drugs Market Size Share by Type (2014-2019)
Figure Global Cryptococcosis Drugs Market Size Market Share by Type (2014-2019)
Table Global Cryptococcosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Cryptococcosis Drugs Market Size Share by Application (2014-2019)
Figure Global Cryptococcosis Drugs Market Size Market Share by Application (2014-2019)
Figure Global Cryptococcosis Drugs Revenue Market Share by Application in 2018
Figure North America Cryptococcosis Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Cryptococcosis Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Cryptococcosis Drugs Market Share (2018-2019)
Table North America Cryptococcosis Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Cryptococcosis Drugs Market Share by Type 2014-2019
Table North America Cryptococcosis Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Cryptococcosis Drugs Market Share by Application 2014-2019
Figure Europe Cryptococcosis Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Cryptococcosis Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Cryptococcosis Drugs Market Share (2018-2019)
Table Europe Cryptococcosis Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Cryptococcosis Drugs Market Share by Type 2014-2019
Table Europe Cryptococcosis Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Cryptococcosis Drugs Market Share by Application 2014-2019
Figure China Cryptococcosis Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Cryptococcosis Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Cryptococcosis Drugs Market Share (2018-2019)
Table China Cryptococcosis Drugs Market Size by Type 2014-2019 (Million US$)
Table China Cryptococcosis Drugs Market Share by Type 2014-2019
Table China Cryptococcosis Drugs Market Size by Application 2014-2019 (Million US$)
Table China Cryptococcosis Drugs Market Share by Application 2014-2019
Figure Japan Cryptococcosis Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Cryptococcosis Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Cryptococcosis Drugs Market Share (2018-2019)
Table Japan Cryptococcosis Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Cryptococcosis Drugs Market Share by Type 2014-2019
Table Japan Cryptococcosis Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Cryptococcosis Drugs Market Share by Application 2014-2019
Figure Southeast Asia Cryptococcosis Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cryptococcosis Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cryptococcosis Drugs Market Share (2018-2019)
Table Southeast Asia Cryptococcosis Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Cryptococcosis Drugs Market Share by Type 2014-2019
Table Southeast Asia Cryptococcosis Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Cryptococcosis Drugs Market Share by Application 2014-2019
Figure India Cryptococcosis Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Cryptococcosis Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Cryptococcosis Drugs Market Share (2018-2019)
Table India Cryptococcosis Drugs Market Size by Type 2014-2019 (Million US$)
Table India Cryptococcosis Drugs Market Share by Type 2014-2019
Table India Cryptococcosis Drugs Market Size by Application 2014-2019 (Million US$)
Table India Cryptococcosis Drugs Market Share by Application 2014-2019
Figure Central & South America Cryptococcosis Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cryptococcosis Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cryptococcosis Drugs Market Share (2018-2019)
Table Central & South America Cryptococcosis Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Cryptococcosis Drugs Market Share by Type 2014-2019
Table Central & South America Cryptococcosis Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Cryptococcosis Drugs Market Share by Application 2014-2019
Table Abbott Company Details
Table Abbott Revenue in Cryptococcosis Drugs Business 2014-2019 (Million US$)
Figure Abbott Revenue Growth Rate in Cryptococcosis Drugs Business (2014-2019)
Table Abbott Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Cryptococcosis Drugs Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Cryptococcosis Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Bristol-Mayers Squibb Company Details
Table Bristol-Mayers Squibb Revenue in Cryptococcosis Drugs Business 2014-2019 (Million US$)
Figure Bristol-Mayers Squibb Revenue Growth Rate in Cryptococcosis Drugs Business (2014-2019)
Table Bristol-Mayers Squibb Recent Development
Table Sigmapharm Laboratories Company Details
Table Sigmapharm Laboratories Revenue in Cryptococcosis Drugs Business 2014-2019 (Million US$)
Figure Sigmapharm Laboratories Revenue Growth Rate in Cryptococcosis Drugs Business (2014-2019)
Table Sigmapharm Laboratories Recent Development
Table Novartis Company Details
Table Novartis Revenue in Cryptococcosis Drugs Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Cryptococcosis Drugs Business (2014-2019)
Table Novartis Recent Development
Table Glenmark Pharmaceuticals Company Details
Table Glenmark Pharmaceuticals Revenue in Cryptococcosis Drugs Business 2014-2019 (Million US$)
Figure Glenmark Pharmaceuticals Revenue Growth Rate in Cryptococcosis Drugs Business (2014-2019)
Table Glenmark Pharmaceuticals Recent Development
Table Global Cryptococcosis Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Cryptococcosis Drugs Market Size Share by Regions (2019-2025)
Figure Global Cryptococcosis Drugs Market Size Share by Regions in 2025
Figure North America Cryptococcosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cryptococcosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Cryptococcosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cryptococcosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cryptococcosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Cryptococcosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cryptococcosis Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Cryptococcosis Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Cryptococcosis Drugs Market Size by Product (2019-2025)
Figure Global Cryptococcosis Drugs Market Size by Product in 2025
Table Global Cryptococcosis Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Cryptococcosis Drugs Market Size by Application (2019-2025)
Figure Global Cryptococcosis Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
体部白癬用薬のグローバル市場：規模・現状・予測2019-2025 Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea.In 2018, the global Tinea Corporis Drugs market size was xx million US$ …- 中枢神経系疾患薬品のグローバル市場：規模・現状・予測2019-2025 A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous systemIn 2018, the global Drugs for Central Nervous System Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of x…
- 気管支拡張薬のグローバル市場：規模・現状・予測2019-2025 Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bac…
- 起立性低血圧治療薬のグローバル市場：規模・現状・予測2019-2025 The increasing prevalence of chronic diseases will also contribute to the growth of the OH drugs market. Orthostatic hypotension is associated with various neurodegenerative diseases, cardiovascular diseases, and diabetes.Orthostatic hypotension is difficult to treat with single-drug therapy because…
- 強迫性障害治療薬のグローバル市場：規模・現状・予測2019-2025 Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").The launch of new molecules is one of the primary drivers for the obsessive-compulsive dis…